Stable ischemic heart disease. Using stress and imaging procedures to direct therapy

Area of Science:

• Cardiology
• Diagnostic Imaging
• Preventive Medicine

Background:

• Exercise electrocardiographic testing is a primary noninvasive method for evaluating coronary artery disease (CAD).
• Its predictive value relies on test accuracy and disease prevalence.
• Absolute indications for testing asymptomatic patients are lacking, but it aids prognosis and treatment decisions.

Purpose of the Study:

• To review the role and methods of exercise testing in assessing coronary artery disease (CAD).
• To discuss the utility of combined imaging techniques and pharmacologic stress tests for CAD evaluation.
• To highlight the importance of exercise testing in guiding medical management of CAD.

Main Methods:

• Review of exercise electrocardiographic testing protocols and interpretation.
• Evaluation of combined radionuclide angiography or echocardiography with exercise.
• Analysis of pharmacologic stress testing methods (dipyridamole-thallium, dobutamine-echocardiography).
• Comparison of diagnostic accuracy for CAD and CAD events.

Main Results:

• Exercise testing provides crucial physiologic data for prognosis and treatment planning in CAD.
• Combined exercise imaging and pharmacologic stress tests demonstrate comparable sensitivity, specificity, and accuracy for CAD detection.
• Coronary angiography remains the gold standard for CAD severity assessment, particularly when integrated with exercise test results.

Conclusions:

• Exercise testing is invaluable for managing patients with suspected or known coronary artery disease (CAD).
• Pharmacologic stress tests offer effective alternatives when exercise testing is not feasible.
• Optimal selection of diagnostic tests and pharmacologic agents is crucial for effective CAD management.